Home > Publications database > Corrigendum to 'Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group': [Ann Oncol 35 (2024) 588-606]. > print

001     298999
005     20250416160615.0
024 7 _ |a 10.1016/j.annonc.2024.11.010
|2 doi
024 7 _ |a pmid:39984357
|2 pmid
024 7 _ |a 0923-7534
|2 ISSN
024 7 _ |a 1569-8041
|2 ISSN
037 _ _ |a DKFZ-2025-00409
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Mosele, M. F.
|b 0
245 _ _ |a Corrigendum to 'Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group': [Ann Oncol 35 (2024) 588-606].
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1744812335_25114
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Volume 36, Issue 4, April 2025, Page 472
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Westphalen, C. B.
|b 1
700 1 _ |a Stenzinger, A.
|b 2
700 1 _ |a Barlesi, F.
|b 3
700 1 _ |a Bayle, A.
|b 4
700 1 _ |a Bièche, I.
|b 5
700 1 _ |a Bonastre, J.
|b 6
700 1 _ |a Castro, E.
|b 7
700 1 _ |a Dienstmann, R.
|b 8
700 1 _ |a Krämer, Alwin
|0 P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0
|b 9
|u dkfz
700 1 _ |a Czarnecka, A. M.
|b 10
700 1 _ |a Meric-Bernstam, F.
|b 11
700 1 _ |a Michiels, S.
|b 12
700 1 _ |a Miller, R.
|b 13
700 1 _ |a Normanno, N.
|b 14
700 1 _ |a Reis-Filho, J.
|b 15
700 1 _ |a Remon, J.
|b 16
700 1 _ |a Robson, M.
|b 17
700 1 _ |a Rouleau, E.
|b 18
700 1 _ |a Scarpa, A.
|b 19
700 1 _ |a Serrano, C.
|b 20
700 1 _ |a Mateo, J.
|b 21
700 1 _ |a André, F.
|b 22
773 _ _ |a 10.1016/j.annonc.2024.11.010
|g p. S0923753424049470
|0 PERI:(DE-600)2003498-2
|n 4
|p 472
|t Annals of oncology
|v 36
|y 2025
|x 0923-7534
909 C O |p VDB
|o oai:inrepo02.dkfz.de:298999
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ANN ONCOL : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF >= 50
|0 StatID:(DE-HGF)9950
|2 StatID
|b ANN ONCOL : 2022
|d 2025-01-07
920 1 _ |0 I:(DE-He78)A360-20160331
|k A360
|l KKE Mol. Hämatologie/Onkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A360-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21